EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome

Mohini A Gunnett, Elizabeth Baker, Cathy Mims, Staci T Self, Hector H Gutierrez, Jennifer S Guimbellot

Frontiers in Pediatrics · 09.03.2023 · 11

DOI: 10.3389/fped.2023.1127659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 09.03.2023. Verfasst von Mohini A Gunnett und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pulmonary and Sleep Medicine, University of Alabama at Birmingham (UAB), Birmingham, AL, United States. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Some infants undergoing newborn screening (NBS) tests have inconclusive sweat chloride test (SCT) results that lead to the designation of Cystic Fibrosis Screen Positive, Inconclusive Diagnosis/CFTR-related metabolic syndrome (CFSPID/CRMS). Some proportion of them transition to a CF diagnosis, but no predictive markers can stratify which are at risk for this transition. We report single-center outcomes of children with CRMS.

Methods

We retrospectively identified all infants born in Alabama from 2008 through 2020 referred to our CF Center with an elevated immunoreactive trypsinogen level (IRT) associated with a cystic fibrosis transmembrane conductance regulator (CFTR) mutation (IRT+/DNA+) who had at least one SCT result documented. Infants were classified per established guidelines as Carrier, CRMS, or CF based on the IRT+/DNA+ and SCT results. The electronic health record was reviewed for follow-up visits until the children received a definitive diagnosis (to carrier or CF) according to current diagnostic guidelines for CF, or through the end of the 2020 year.

Results

Of the 1,346 infants with IRT+ and at least 1 CFTR mutation identified (IRT+/DNA+), 63 (4.7%) were designated as CRMS. Of these infants, 12 (19.1%) transitioned to Carrier status (CRMS-Carrier), 40 (63.5%) of them remained CRMS status (CRMS-Persistent) and 11 (17.5%) of them transitioned to a diagnosis of CF (CRMS-CF). Of the 11 children in the CRMS-CF group, 4 (36%) had an initial SCT 30–39 mmol/L, 4 (36%) had an initial SCT 40–49 mmol/L and 3 (27%) had an initial SCT 50–59 mmol/L. These children also had higher initial sweat tests and greater yearly increases in sweat chloride values than others with CRMS. We found that in comparison to children in the CRMS- P group, a greater proportion of children in the CRMS-CF group cultured bacteria like methicillin-resistant Staphylococcus aureus, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa, had smaller weight-for-height percentiles and remained smaller over time despite slightly greater growth.

Conclusion

Infants with an inconclusive diagnosis of CF should continue to receive annual care and management given their potential risk of transition to CF. Further research is needed to assess whether certain phenotypic patterns, clinical symptoms, diagnostic tests or biomarkers could better stratify these children.

Schlagwörter

Stichwörter der Autor:innen

CFCF screen positive, inconclusive diagnosis (CFSPID)/CFTR-related metabolic synd…CFSPID/CRMSCFTR (cystic fibrosis transmembrane conductance regulator)NBS (Newborn screening)SCT (sweat chloride testing)cystic fibrosis

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pulmonary and Sleep Medicine, University of Alabama at Birmingham (UAB), Birmingham, AL, United States.
  • Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham (UAB), Birmingham, AL, United States.
  • Department of Sociology, University of Alabama at Birmingham (UAB), Birmingham, AL, United States.

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Gunnett, M. A., Baker, E., Mims, C., Self, S. T., Gutierrez, H. H., & Guimbellot, J. S. (2023). Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1127659

Vancouver

Gunnett MA, Baker E, Mims C, Self ST, Gutierrez HH, Guimbellot JS. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1127659

BibTeX
@article{Gunnett2023,
  author = {Gunnett, Mohini A and Baker, Elizabeth and Mims, Cathy and Self, Staci T and Gutierrez, Hector H and Guimbellot, Jennifer S},
  title = {Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome},
  journal = {Frontiers in Pediatrics},
  year = {2023},
  volume = {11},
  doi = {10.3389/fped.2023.1127659}
}
Kostenlos starten →